We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Surgery Reverses Obesity-Related Hypogonadism

By HospiMedica International staff writers
Posted on 06 Jun 2018
A new study shows that weight loss after obesity surgery can rapidly restore testosterone production and sex drive in morbidly obese men.

Researchers at the University of Padova (Italy) conducted a study involving 29 obese men (average age 40.5 years, average body mass index (BMI) 43.4 kg/m2) who underwent a bariatric sleeve gastrectomy procedure. Blood tests were performed before and one month after surgery to measure total plasma testosterone, the sex hormones dihydrotestosterone (DHT), estradiol, luteinising hormone (LH), follicle-stimulating hormone (FSH), sex hormone binding globulin (SHBG), prostatic-specific antigen (PSA), and leptin. A group of 19 healthy age-matched, non-obese, male subjects served as a control.

Among the obese subjects, 51.6% suffered from hypogonadism, and of those who had subnormal total testosterone, those with metabolic syndrome (45.2%) showed lower plasma testosterone than men without metabolic syndrome. BMI and waist circumference were found to be negatively correlated with total testosterone and plasma LH levels. The obese males had lower plasma testosterone (10.8 nmol/L) than healthy subjects (15.7 nmol/L), higher estradiol levels, and lower LH and FSH levels. No differences were observed between the two groups in their DHT and PSA levels.

The results revealed that one month after the sleeve gastrectomy procedure, obese subjects showed a significant weight reduction (averaging 17.2 kg) and the proportion with hypogonadism had fallen to just 11.6%. At the same time, average testosterone levels increased by 85%, to a level greater than that observed in the healthy control group (18.9 nmol/L), and estradiol levels fell by 35%. Surprisingly, PSA levels rose by 70%. The study was presented at the European Congress on Obesity (ECO), held during May 2018 in Vienna (Austria).

“Obesity in men is associated with hypogonadism, a condition in which production of testosterone is reduced, while estrogen levels are elevated,” said senior author Professor Marco Rossato, MD, and colleagues. “These effects seem to be the result of excess body fat interfering with sex steroid metabolism which leads to increased aromatization of androgens (such as testosterone) into estrogens within the adipose tissue itself. It follows that weight loss should improve this hormonal imbalance, and contribute to a reversal of hypogonadism.”

Hypogonadism in men refers to a diminished functional activity of the gonads, resulting in diminished testosterone biosynthesis. Other hormones produced by the gonads that hypogonadism can decrease include progesterone, DHEA, anti-Müllerian hormone, activin, and inhibin. In men, it can cause reduced body hair and beard, enlarged breasts, loss of muscle, and sexual difficulties.

Related Links:
University of Padova


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
LED Examination Lamp
Clarity 50 LED
New
Mini C-arm Imaging System
Fluoroscan InSight FD

Latest Surgical Techniques News

Novel Combination of Surgery and Embolization for Subdural Hematoma Reduces Risk of Recurrence

Novel Sensory System Enables Real-Time Intra-Articular Pressure Monitoring

Endoscopic Surgical System Enables Remote Robot-Assisted Laparoscopic Hysterectomy